HuGE Literature Finder
Records 1-30
|
OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis.
European journal of cancer (Oxford, England : 1990) 2021 Jul 154 209-216. Davey Matthew G, Richard Vinitha, Lowery Aoife J, Kerin Michael |
|
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan.
Scientific reports 2021 Jul 11 (1): 14906. Abdel-Razeq Hikmat, Abujamous Lama, Abunasser Mahmoud, Edaily Sara, Bater Ray |
|
A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2.
Molecular biology reports 2021 Jun . Sahin Ibrahim, Saat Hani |
|
Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.
Gynecologic oncology 2021 Jun . Safra Tamar, Waissengrin Barliz, Gerber Deanna, Bernstein-Molho Rinat, Klorin Geula, Salman Lina, Josephy Dana, Chen-Shtoyerman Rakefet, Bruchim Ilan, Frey Melissa K, Pothuri Bhavana, Muggia Fran |
|
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
NPJ breast cancer 2021 Jun 7 (1): 76. Li Na, Lim Belle W X, Thompson Ella R, McInerny Simone, Zethoven Magnus, Cheasley Dane, Rowley Simone M, Wong-Brown Michelle W, Devereux Lisa, Gorringe Kylie L, Sloan Erica K, Trainer Alison, Scott Rodney J, James Paul A, Campbell Ian |
|
Malignant salivary gland tumours in families with breast cancer susceptibility.
Virchows Archiv : an international journal of pathology 2021 Jun . Ripamonti Carla B, Bossi Paolo, Manoukian Siranoush, Locati Laura, Colombo Mara, Carcangiu Maria L, Vingiani Andrea, Licitra Lisa, Radice Pao |
|
Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.
JCO global oncology 2021 Jun 7 849-861. Gupta Sudeep, Rajappa Senthil, Advani Suresh, Agarwal Amit, Aggarwal Shyam, Goswami Chanchal, Palanki Satya Dattatreya, Arya Devavrat, Patil Shekhar, Kodagali Roh |
|
RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers.
Cancers 2021 Jun 13 (13): . Reye Gina, Huang Xuan, Britt Kara L, Meinert Christoph, Blick Tony, Xu Yannan, Momot Konstantin I, Lloyd Thomas, Northey Jason J, Thompson Erik W, Hugo Honor |
|
Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.
Journal of personalized medicine 2021 Jun 11 (7): . Bekos Christine, Grimm Christoph, Kranawetter Marlene, Polterauer Stephan, Oberndorfer Felicitas, Tan Yen, Müllauer Leonhard, Singer Christian |
|
Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
International journal of molecular sciences 2021 May 22 (11): . Zuntini Roberta, Bonora Elena, Pradella Laura Maria, Amato Laura Benedetta, Vidone Michele, De Fanti Sara, Catucci Irene, Cortesi Laura, Medici Veronica, Ferrari Simona, Gasparre Giuseppe, Peterlongo Paolo, Sazzini Marco, Turchetti Danie |
|
NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer.
Scientific reports 2021 May 11 (1): 11125. Marchetti Claudia, D'Indinosante Marco, Bottoni Carolina, Di Ilio Chiara, Di Berardino Stefano, Costantini Barbara, Minucci Angelo, Vertechy Laura, Scambia Giovanni, Fagotti An |
|
Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina.
Cancers 2021 May 13 (11): . Solano Angela R, Mele Pablo G, Jalil Fernanda S, Liria Natalia C, Podesta Ernesto J, Gutiérrez Leandro |
|
A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients.
Journal of clinical pharmacology 2021 Apr . Stodtmann Sven, Nuthalapati Silpa, Eckert Doerthe, Kasichayanula Sreeneeranj, Joshi Rujuta, Bach Bruce A, Mensing Sven, Menon Rajeev, Xiong H |
|
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Gynecologic oncology 2021 Apr . Artioli Grazia, Giannone Gaia, Valabrega Giorgio, Maggiorotto Furio, Genta Sofia, Pignata Sandro, Lorusso Domenica, Cormio Gennaro, Scalone Simona, Nicoletto Maria Ornella, Greco Filippo, Rossi Emanuela, Spagnoletti Ilaria, De Giorgi Ugo, Orditura Michele, Mosconi Anna Maria, Kardhashi Anila, Bogliolo Stefano, Borgato Luc |
|
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.
European journal of breast health 2021 Apr 17 (2): 123-127. Atci Muhammed Mustafa, Geredeli Çaglayan, Ay Seval, Sakin Abdullah, Ertürk Biray, Seçmeler Saban, Arici Serdar, Çekin Ruhper, Yasar Nurgül, Can Orçun, Cihan Sener, Gümüs Mahm |
|
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.
Gynecologic oncology 2021 Apr . Giannone G, Scotto G, Katsaros D, De Giorgi U, Farolfi A, Borella F, Cosma S, Ferrero A, Mangiacotti S, Villa M, Tuninetti V, Ghisoni E, Turinetto M, Mittica G, Gemmiti S, Zavallone L, Aglietta M, Pasini B, Di Maio M, Valabrega |
|
A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel.
Familial cancer 2021 Mar . Majidzadeh-A Keivan, Zarinfam Shiva, Abdoli Nasrin, Yadegari Fatemeh, Esmaeili Rezvan, Farahmand Leila, Teimourzadeh Azin, Taghizadeh Mahdieh, Salehi Mansoor, Zamani Moham |
|
Causal Associations between Serum Urea and Cancer: A Mendelian Randomization Study.
Genes 2021 Mar 12 (4): . Sun Yandi, Li Jingjia, Qu Zihao, Yang Ze, Jia Xueyao, Lin Yindan, He Qian, Zhang Lihong, Luo Y |
|
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.
NPJ breast cancer 2021 Mar 7 (1): 29. Kalra Maitri, Tong Yan, Jones David R, Walsh Tom, Danso Michael A, Ma Cynthia X, Silverman Paula, King Mary-Claire, Badve Sunil S, Perkins Susan M, Miller Kathy |
|
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
Journal of translational medicine 2021 Mar 19 (1): 108. Ben Ayed-Guerfali Dorra, Ben Kridis-Rejab Wala, Ammous-Boukhris Nihel, Ayadi Wajdi, Charfi Slim, Khanfir Afef, Sellami-Boudawara Tahia, Frikha Mounir, Daoud Jamel, Mokdad-Gargouri Ra |
|
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival.
Aging 2021 Mar 13 (6): 8975-8988. Shao Fengping, Duan Yaoyun, Zhao Yunhe, Li Yinguang, Liu Jun, Zhang Cai, He Shanya |
|
The results of multigene panel sequencing in Slovak HBOC families.
Neoplasma 2021 Mar . Konecny Michal, Kosova Klaudia, Tilandyova Petra, Wachsmannova Lenka, Baldovic Marian, Krajcovic Juraj, Patlevicova Andrea, Markus Jan, Ciernikova So |
|
Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.
Breast cancer research and treatment 2021 Feb . Liu Miao, Xie Fei, Liu Miaoyu, Zhang Yi, Wang S |
|
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.
Journal of the National Cancer Institute 2021 . Emens Leisha A, Molinero Luciana, Loi Sherene, Rugo Hope S, Schneeweiss Andreas, Diéras Véronique, Iwata Hiroji, Barrios Carlos H, Nechaeva Marina, Duc Anh Nguyen, Chui Stephen Y, Husain Amreen, Winer Eric P, Adams Sylvia, Schmid Pet |
|
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
The oncologist 2021 Feb . Botrus Gehan, Kosirorek Heidi, Sonbol Mohamad Bassam, Kusne Yael, Uson Junior Pedro Luiz Serrano, Borad Mitesh J, Ahn Daniel H, Kasi Pashtoon M, Drusbosky Leylah M, Dada Hiba, Surapaneni Phani Keerthi, Starr Jason, Ritter Ashton, McMillan Jessica, Wylie Natasha, Mody Kabir, Bekaii-Saab Tanios |
|
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.
Breast (Edinburgh, Scotland) 2021 Feb 56 26-34. Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M |
|
Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.
The breast journal 2021 Feb . Kanana Nayroz, Ben David Meirav A, Nissan Noam, Yagil Yael, Shalmon Anat, Halshtok Osnat, Gotlieb Michael, Faermann Renata, Klang Eyal, Samoocha David, Yassin Mohammad, Davidson Tima, Zippel Dov, Madorsky Feldman Dana, Friedman Eitan, Kaidar-Person Orit, Sklair Levy Mi |
|
Germline and Somatic mutations in postmenopausal breast cancer patients.
Clinics (Sao Paulo, Brazil) 2021 76 e2837. Nagy Tauana Rodrigues, Maistro Simone, Encinas Giselly, Katayama Maria Lucia Hirata, Pereira Glaucia Fernanda de Lima, Gaburo-Júnior Nelson, Franco Lucas Augusto Moyses, Gouvêa Ana Carolina Ribeiro Chaves de, Diz Maria Del Pilar Estevez, Leite Luiz Antonio Senna, Folgueira Maria Aparecida Azevedo Koi |
|
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
PloS one 2021 16 (1): e0245362. Boujemaa Maroua, Hamdi Yosr, Mejri Nesrine, Romdhane Lilia, Ghedira Kais, Bouaziz Hanen, El Benna Houda, Labidi Soumaya, Dallali Hamza, Jaidane Olfa, Ben Nasr Sonia, Haddaoui Abderrazek, Rahal Khaled, Abdelhak Sonia, Boussen Hamouda, Boubaker Mohamed Sam |
|
Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.
BMJ (Clinical research ed.) 2021 02 372 n214. Mn Weedon, L Jackson, Jw Harrison, Ks Ruth, J Tyrrell, At Hattersley, Cf Wrig |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jul 27, 2021
- Content source: